Groups launch CRC screening campaign as incidence declines

WASHINGTON – Several dozen organizations have joined together to help increase colorectal cancer screening rates to 80% of all Americans by 2018, citing the success of campaigns over the past decade...

Field of Interest: Oncology
Type: News Item

Nivolumab extends survival in advanced melanoma

An immunomodulator that targets the PD-1 pathway effected sustained remission in 31% of patients who took it for advanced melanoma. Remission lasted a median of 2 years, with 1- and 2-year overall...

Field of Interest: Oncology
Type: News Item

VIDEO: How to improve cancer survivorship planning

BRUSSELS – National Cancer Institute Director Catherine Alfano, Ph.D., summarizes the institute’s work on improving cancer survivor planning, better coordinating survivor care, and gathering new data...

Field of Interest: Oncology
Type: News Item

U.K. ahead of U.S.A. in cancer survivorship planning

BRUSSELS – Cancer survivorship planning in the United Kingdom is ahead of the United States and the rest of Europe with the recent rollout of a model care plan for cancer patients, along with a guide...

Field of Interest: Oncology
Type: News Item

Fecal immunochemical tests detect most colorectal cancers

Fecal immunochemical tests have an overall diagnostic accuracy of 95% for the detection of colorectal cancer, according to the results of a meta-analysis just published in the Annals of Internal...

Field of Interest: Oncology
Type: News Item

Immunosuppressive therapy ups risk for skin cancers

HOLLYWOOD, FLA. – Current and previous use of thiopurines, biologics, and combination therapies are all independent risk factors for skin cancer, according to expert analysis given at a conference on...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.